P/B
—
XWELL
XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresSpa. XpresTest, Naples Wax Center and Treat. XpresSpa provides travelers with premium spa services, including massage, nail and skin care, as well as spa and travel products. Treat is a travel health and wellness brand that offers in-airport spa. XpresTest provides COVID-19 screening and diagnostic testing in partnership with the CDC. Naples Wax Center operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.
XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresSpa. XpresTest, Naples Wax Center and Treat. XpresSpa provides travelers with premium spa services, including massage, nail and skin care, as well as spa and travel products. Treat is a travel health and wellness brand that offers in-airport spa. XpresTest provides COVID-19 screening and diagnostic testing in partnership with the CDC. Naples Wax Center operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.
$7.1M
Market Cap • 10/1/2026
2006
(20 years)
Founded
2010
(16 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
0,2
P/EBITDA
—
P/OCF
—
P/FCF
—
P/E
—
BVPS
—
EPS
—
Market Cap
Market Cap
7,1M
EV
12,7M
EV/Revenue
0,4
EV/EBITDA
-0,8
EV/EBIT
-0,7
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
-347,6%
Total Yield
-347,6%
Payout
0%
Retained Earnings
-503,1M
Profitability
Gross Margin
34,3%
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
0%
Capex/Revenue
7,8%
Capex/D&A
261,8%
Capex/OCF
-19,6%
SBC/OCF
—
% PPE
11,9%
% Goodwill
0%
ROE
—
ROIC
—
Growth
CAGR Revenue 5Y
9,3%
CAGR Op. Income 5Y
-11,4%
CAGR Net Income 5Y
-4,8%
CAGR EPS 5Y
-6,4%
CAGR OCF 5Y
-5,7%
Leverage
N.D./EBITDA
0,3
Debt/Equity
0%
Current Ratio
2,3
Quick Ratio
2
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!